VALEANT PHARMACEUTICALS INTL

VRX stock holders 13F

7 superinvestors reported owning VRX (Common Stock) according to the gurus' 2014 Q4 reports.

Top 5 gurus who own (VRX) VALEANT PHARMACEUTICALS INTL

The top 5 super investors (holders) owning VRX (by the percentage (%) of portfolio) are Glenn Greenberg - Brave Warrior Advisors (30.53%), Jeffrey Ubben - ValueAct Holdings (17.38%), Quincy Lee - Ancient Art (Teton Capital) (9.08%), Ole Andreas Halvorsen - Viking Global Investors (5.96%) and Stephen Mandel - Lone Pine Capital (5.05%) as of their 2014 Q4 reports.

To check the latest activities of the top VRX shareholders between value investors, please click on the "Activity" tab.

To see the historical data of VRX's holders please click on the "2014 Q4" dropdown menu and select the date.

# of holders: 7

Period: 2014 Q4

Type: Common Stock

History

% change to
Portfolio

Glenn Greenberg

Brave Warrior Advisors

30.53%

6,126,609

$143.11

$876,779,000

-6.98% (-459,973)

-2.29%

Jeffrey Ubben

ValueAct Holdings

17.38%

19,383,877

$143.11

$2,774,027,000

+2.43% (+460,000)

+0.41%

Nathaniel Simons

Meritage Group

4.23%

1,084,304

$143.11

$155,175,000

-31.44% (-497,347)

-1.94%

Ole Andreas Halvorsen

Viking Global Investors

5.96%

9,077,007

$143.11

$1,299,010,000

-8.94% (-890,683)

-0.59%

Quincy Lee

Ancient Art (Teton Capital)

9.08%

243,863

$143.11

$34,899,000

Ravenel Boykin Curry IV

Eagle Capital Management

2.11%

3,914,082

$143.11

$560,144,000

-0.29% (-11,392)

-0.01%

Stephen Mandel

Lone Pine Capital

5.05%

8,250,886

$143.11

$1,180,784,295

-24.90% (-2,735,054)

-1.67%

AVG reported hold price*: $143.11

Completely sold out

History

Name

Company

Sold
Shares*

% change to
Portfolio

Frederick (Shad) Rowe

Greenbrier Partners Capital Management

20,000

-0.64%

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.